Walgreens sale to private equity firm is 'alive': report
CNBC’s David Faber said Walgreens' rumored sale to Sycamore Partners was "mostly dead a couple of weeks ago" but he was now upgrading the deal to "alive."
CNBC’s David Faber said Walgreens' rumored sale to Sycamore Partners was "mostly dead a couple of weeks ago" but he was now upgrading the deal to "alive."
The Federal Trade Commission received filings for about 200 transactions over a week's span, representing a fourfold increase.
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
The rebrand at the healthcare data analytics company follows a string of antitrust lawsuits and debt refinancing.
Former Trump adviser Steve Bannon warned Republicans against taking a “meat ax” to Medicaid to pay for Trump’s priorities.
Those laid off Saturday included HHS employees that evaluate the safety of medical devices and conduct oversight of Affordable Care Act exchanges.
The former federal official under President Barack Obama doesn’t see value-based care as a partisan issue.
Grant funding uncertainty has jeopardized the sustainability of research projects and discouraged researchers.
The investment will help Abridge invest in additional AI tools.
Innovaccer announced a $275 million funding round last month.
Avandra has developed a de-identified imaging and clinical data network for researchers, medical device companies and pharmaceutical manufacturers.